Key Takeaways
- Neurology adoption is shaped by academic credibility and institutional networks as much as by promotional reach.
- Centers of Excellence often influence referral, guidelines and standards of care.
- Medical Affairs and Commercial must operate as one scientific partner in the eyes of physicians.
- Adult and pediatric neurology pathways can require different expansion models.
Commercial success in neurology is rarely determined by clinical efficacy alone.
Academic physicians—particularly within major neurological Centers of Excellence—evaluate therapies within a broader context that includes scientific credibility, institutional trust, implementation feasibility and long-term clinical value.
PharmaKonsult’s work in this area is reflected in neurology rare disease commercialization and related insights such as successful product commercialization in neurology.
Executive opinion paper
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.
About Joseph McCoy
Joseph McCoy is Founder and Principal Consultant of PharmaKonsult and an executive commercial strategy advisor with more than three decades of pharmaceutical and biotechnology commercial leadership experience across neuroscience, rare disease, endocrinology, institutional healthcare and specialty pharmaceuticals.
